• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    P

    Perm State Medical Academy

    院校EST. 1916
    450论文总数
    1,381引用总数

    Perm State Medical University named after Academician E. A. Wagner (PSMU; Russian: Пермский государственный медицинский университет имени академика Е. А. Вагнера; ПГМУ им. академика Е. А. Вагнера; ПГМУ, Permskiy gosudarstvennyy meditsinskiy universitet imeni akademika Ye. A. Vagnera; PGMU im. akademika Ye. A. Vagnera) is a state medical university in Volga Federal District of Russia located in the city of Perm, the administrative centre of Perm Krai.

    论文量&引用量时间轴

    机构学者

    排序
    V. L. Gein
    V. L. Gein
    Russian Ministry of Health State Higher Professional Educational Institution, Perm’ State Pharmaceutical Academy
    论文:15引用:0H-index:0
    N. Koziolova
    N. Koziolova
    Perm State Med Univ
    论文:12引用:0H-index:0
    Lf Gein
    Lf Gein
    PERM PHARM INST
    论文:12引用:0H-index:0
    N. Koziolova
    N. Koziolova
    Perm State Medical Academy
    论文:9引用:0H-index:0
    A. S. Galyavich
    A. S. Galyavich
    The Republican Center for Cardiovascular Diseases of State Autonomous Institution of Health, Kazan State Medical University
    论文:7引用:0H-index:0
    Anton V. Dolzhenko
    Anton V. Dolzhenko
    Faculty of Science, National University of Singapore
    论文:6引用:0H-index:0
    T. V. Gavrilova
    T. V. Gavrilova
    Institute of Ecology and Genetics of Microorganisms, Russian Academy of Sciences
    论文:6引用:0H-index:0
    B. Ya. Syropyatov
    B. Ya. Syropyatov
    Perm State Pharmaceutical Academy
    论文:6引用:0H-index:0
    M. V. Vasilyuk
    M. V. Vasilyuk
    Perm′ State Pharm. Acad
    论文:5引用:0H-index:0

    论文(450)

    年份
    起
    –
    止
    排序
    1ПАТОЛОГИЧЕСКИЕ ТИПЫ ЖЕЛУДОЧНОЙ СЕКРЕЦИИ
    Д.В. Белоус, А.А. Давыдова

    Данная работа посвящена анализу нарушений секреторной функции желудка, которые являются ключевым звеном в патогенезе заболеваний желудочно-кишечного тракта. В тексте подробно рассматриваются нейрогенные и гуморальные механизмы регуляции выработки соляной кислоты, включая влияние симпатической и парасимпатической нервных систем, гастрина и гистамина. Обоснована тесная взаимосвязь между количественными сдвигами секреции (гипер- и гипохлоргидрия) и развитием системных осложнений, в частности синдромы мальдигестии и мальабсорбции. Особое внимание уделено патофизиологической классификации типов желудочной секреции (возбудимый, инертный, астенический, тормозной и хаотический), предложенной С.С. Зимницким и переосмысленной в современной медицине. Для каждого варианта подробно раскрыты механизмы патогенеза, этиологические факторы и специфические клинические проявления. Патологические типы секреции характеризуются различными показателями, такими как количество секретируемого желудочного сока за единицу времени, длительность нарастания и убывания секреции. Данные получают на основе анализа результатов фракционного зондирования. Рассмотрено значение метода диагностики в дифференциации тяжелых органических поражений, таких как синдром Золлингера–Эллисона, язвенная болезнь и хронический атрофический гастрит. Работа подчеркивает прогностическую важность оценки динамики секреторного процесса для постановки диагноза.

    2026Международный студенческий научный вестник (International Student Scientific Herald)(2026)
    引用
    AI阅读
    加入学术空间
    2Pancytopenia in HIV-positive Patients with Congestive Heart Failure: Mechanisms, Diagnosis and Treatment Approaches
    Emmanuel Ifeanyi Obeagu, Olga G Goryacheva

    Pancytopenia, characterized by the simultaneous reduction of red blood cells, white blood cells, and platelets, is a significant hematological complication in individuals living with human immunodeficiency virus (HIV). Its presence often reflects disease progression, immune suppression, and concurrent opportunistic infections. When pancytopenia coexists with congestive heart failure (CHF) - a condition increasingly prevalent among HIV-positive patients due to chronic inflammation, antiretroviral therapy (ART)-associated cardiotoxicity, and aging - the clinical burden intensifies, leading to diagnostic and therapeutic dilemmas. This review aims to examine the underlying mechanisms, diagnostic challenges, and management strategies of pancytopenia in HIV-positive patients with CHF. It explores the multifactorial pathophysiology, including direct viral effects on the bone marrow, drug-induced cytopenias, opportunistic infections, nutritional deficiencies, and CHF-related impairments in erythropoietin and thrombopoietin production. Additionally, the review highlights overlapping symptoms that complicate diagnosis and evaluates current treatment options ranging from ART optimization to hematopoietic growth factors and supportive care.

    2025Annals of medicine and surgery (2012)(2025)引用:2
    引用
    AI阅读
    加入学术空间
    3Chronic Heart Failure with Preserved Ejection Fraction: Current Understanding of the Problem
    O. A. Ponomareva, V. Е. Vladimirsky, I. V. Petukhova

    This review is aimed at the investigation of diagnostic approaches and therapeutic options for patients with chronic cardiac insufficiency with preserved ejection fraction. Chronic cardiac insufficiency with preserved ejection fraction can result from various cardiovascular diseases and is observed in more than 50 % of patients with chronic circulatory failure. Although clinical guidelines exist, the criteria for diagnosing this form of heart failure do not always allow to detect the disease accurately, which can affect subsequent treatment negatively. Modern randomized clinical trials demonstrate that medications from the group of sodium-glucose cotransporter type-2 inhibitors significantly improve clinical outcomes in patients with circulatory failure, justifying their inclusion in treatment regimen. However, the optimal time for starting this therapy is still questionable compared to the administration of other medications recommended for chronic cardiac insufficiency. Considering high incidence, difficulties in diagnosis and treatment for circulatory failure with preserved ejection fraction in practice, the development of practical algorithms for detecting and managing this condition is one of the most important tasks.

    2025Perm Medical Journal(2025)引用:1
    引用
    AI阅读
    加入学术空间
    4Current Hypertension Treatment Possibilities and Tactics in Patients with Comorbidities. the Role of Selective Imidazoline Receptor Agonists. Expert Opinion
    T. V. Pecherina, G. A. Chumakova,Yu. I. Grinshtein, O. Yu. Donirova, N. V. Zakharchuk, V. V. Kashtalap, T. A. Petrichko, L. I. Syromyatnikova, O. V. Fedorishina, S. М. Cherepenin

    Hypertension (HTN) is a serious public health problem. Despite advances in diagnosis and public awareness, the percentage of controlled cases remains low, especially among men and the elderly. The main challenges are related to comorbidities such as obesity, diabetes, chronic kidney disease, and obstructive sleep apnea, which worsen the prognosis and increase the risk of cardiovascular events. The approach to HTN treatment should be individualized and take into account specific disease phenotypes and comorbidities. It is important to identify patients with increased sympathetic nervous system activity, as this group experiences the greatest difficulties in blood pressure control. Moxonidine, a centrally acting agent, selectively stimulates imidazoline receptors in the brain, causing a decrease in sympathetic activity and effective reduction in blood pressure. The need for a personalized approach to HTN therapy is driven by the growing number of patients with multiple comorbidities and complex pathogenesis. New approaches, including early initiation of combination therapy and targeted management of metabolic risk factors, will reduce cardiovascular morbidity and mortality. Moxonidine plays a key role within antihypertensive medications due to its unique mechanism of action and ability to positively impact a wide range of HTN-related pathologies

    2025Cardiovascular Therapy and Prevention(2025)
    引用
    AI阅读
    加入学术空间
    5Clinical Patterns of Hard Dental Tissue Lesions in Indian Medical Students: a Cross-Sectional Study
    O. S. Gileva, M. A. Sycheva

    Relevance. This study reports the findings of a dental examination conducted among international students from various Indian states enrolled at a Russian medical university. The assessment focused on the condition of hard dental tissues and the quality of previously placed esthetic-functional restorations. The results provide a basis for determining the scope and priorities of conservative and restorative dental care needed to support and maintain oral health throughout the students’ academic training. Objective. To examine the structure, prevalence, and severity of hard dental tissue lesions and to evaluate the need for conservative treatment of carious and non-carious lesions in Indian students enrolled at a medical university. Materials and methods. A total of 200 international students participated in the study; their hard dental tissue status was evaluated by measuring caries prevalence (%), quantifying caries experience using the DMFT index, and identifying non-carious lesions. The diagnostic evaluation included a thorough visual-tactile examination, digital fiber-optic trans-illumination (FOTI) for caries detection, and an assessment of existing restorations according to Ryge’s clinical criteria. Results. The findings revealed a heterogeneous clinical pattern of hard dental tissue lesions among Indian students. This pattern was characterized by moderate caries prevalence and low caries experience, a high prevalence of dental fluorosis, and a considerable need for replacement of unsatisfactory composite restorations, predominantly on posterior teeth. Conclusion. The cross-sectional study identified a heterogeneous profile of hard dental tissue conditions among Indian students, characterized by: dental caries of moderate prevalence and low severity (68.9%; DMFT = 2.68 ± 0.20); endemic dental fluorosis (24.1%), predominantly presenting as diffuse or discrete white enamel opacities (71.2%); enamel hypoplasia (7.5%), mainly in the form of demarcated enamel defects (78.6%); a high proportion (53.2%) of previously placed posterior composite restorations demonstrating clinical deficiencies and requiring replacement.

    2025Pediatric dentistry and dental prophylaxis(2025)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 450 篇论文

    合作机构(98)

    Perm State Pharmaceutical Academy合作论文 30
    俄罗斯科学院合作论文 18
    Sechenov University合作论文 11
    Volgograd State Medical University合作论文 10
    Perm National Research Polytechnic University合作论文 8
    Rostov State Medical University合作论文 8
    Chelyabinsk State Medical Academy合作论文 7
    Ural State Medical University合作论文 7
    Kursk State Medical University合作论文 7
    Perm Regional Oncology Center合作论文 7

    机构统计